NCT06811740 2025-02-18
Treatable Traits of Severe Asthma
Beijing Chao Yang Hospital
Phase NA Enrolling by invitation
Clinical Trials
22 trialsNCT00282516 2025-02-10
Asthma In-Home Monitoring (AIM) Trial
Tripler Army Medical Center
Phase NA Completed
NCT03916237 2023-10-19
CREST
MetroHealth Medical Center
Phase NA Completed
NCT02517099 2023-03-06
PrIGMa
Imperial College London
Phase 2 Completed
NCT04680117 2022-10-31
SevAsthma
Assistance Publique - HĂ´pitaux de Paris
Phase NA Unknown
NCT02872298 2022-04-12
RELIEF-1
Nuvaira, Inc.
Phase NA Terminated
NCT02808689 2021-04-01
FAst
The Cleveland Clinic
Phase NA Completed
NCT00555607 2021-03-03
BIOAIR
Karolinska Institutet
Phase NA Active not recruiting
NCT01103037 2020-12-19
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
Novartis
Phase 2 Terminated
NCT02458482 2020-11-13
Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
Vanderbilt University Medical Center
Phase NA Withdrawn
NCT03369847 2019-07-18
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Phase 4 Completed
NCT03387241 2019-04-29
Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Unknown
NCT03630432 2018-08-14
PRODA01
NHS Greater Glasgow and Clyde
Phase NA Unknown
NCT02022761 2018-05-30
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
Phase 1 Completed
NCT00455923 2018-02-05
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
Phase 4 Completed
NCT01777360 2017-11-07
ASMATHERM
Assistance Publique - HĂ´pitaux de Paris
Phase 3 Unknown
NCT02105012 2017-06-06
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
Phase 2 Completed
NCT00461500 2017-03-03
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Phase 4 Completed
NCT01089322 2017-02-16
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Phase 4 Completed
NCT00621946 2014-02-04
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT00646516 2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3 Completed
NCT00850265 2009-03-27
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Hospital General de Requena
Phase NA Completed